# 20/20 Biolabs, Inc.: Form S-1/A, filed Jan 21, 2026

- Company: [20/20 Biolabs, Inc.](/companies/aidx.md) (CIK 1139685)
- Form: S-1/A
- Filed: 2026-01-21
- Accepted by EDGAR: Jan 21, 2026, 21:50 ET
- Period: not reported
- Accession: 0001213900-26-006263
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1139685/000121390026006263/ea0273270-s1a1_biolabs.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1139685/000121390026006263/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1139685/000121390026006263/ea0273270-s1a1_biolabs.htm

Filed Jan 21, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-006263. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.